The 7th National Formulary of India (NFI) was launched on 21 September 2026 at the Dr. Ambedkar International Centre in New Delhi. Smt. Anupriya Patel, Minister of State for Health & Family Welfare and Chemicals & Fertilisers, unveiled the publication during the 6th National Pharmacovigilance Week Campaign.
National Formulary of India
The National Formulary of India is a reference publication for healthcare professionals in India. It contains standard information on medicines and supports the rational use of medicines in clinical practice and pharmacy education.
Indian Pharmacopoeia Commission
The Indian Pharmacopoeia Commission (IPC) is a statutory institution under the Ministry of Health and Family Welfare. It publishes the National Formulary of India and has issued regular updates to the series since 2008.
Pharmacovigilance Framework in India
The 6th National Pharmacovigilance Week Campaign was held from 17 to 23 September 2026. Its theme was “Promoting Rational Use of Medicines through Pharmacovigilance: A Step Towards Safer Healthcare”, and it was coordinated by the National Coordination Centre-Pharmacovigilance Programme of India at the Indian Pharmacopoeia Commission, Ghaziabad.
Important Facts for Exams
- The previous 6th edition of the National Formulary of India was launched in October 2021.
- The National Formulary of India is used as a reference for rational and safe use of medicines.
- The Indian Pharmacopoeia Commission has published updates to the National Formulary of India since 2008.
- The Pharmacy Council of India regulates pharmacy education in India, including PharmD programmes.
Publication and Academic Use
The Indian Pharmacopoeia Commission urged the Pharmacy Council of India on 1 September 2026 to direct PharmD colleges to ensure participation in the launch and scientific sessions. The updated NFI is intended for use by healthcare professionals, teachers, and students in medicine and pharmacy.
